Beyond Air, Inc.(XAIR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

XAIR Beyond Air, Inc.

Post-Mkt 02-09 16:15:23 EST

1.16

+0.01

+0.87%

盘后1.16

+0.000.00%

16:10 EST

High1.25	Low1.14	Vol334.46K
Open1.18	D1 Closing1.15	Amplitude9.27%
Mkt Cap12.21M	Tradable Cap10.63M	Total Shares10.53M
T/O398.09K	T/O Rate3.65%	Tradable Shares9.16M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"XAIR","market":"US","secType":"STK","nameCN":"Beyond Air, Inc.","latestPrice":1.16,"timestamp":1770670800000,"preClose":1.15,"halted":0,"volume":334460,"hourTrading":{"tag":"盘后","latestPrice":1.16,"preClose":1.16,"latestTime":"16:10 EST","volume":139,"amount":161.23999999999998,"timestamp":1770671404517,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.008695652173913052,"floatShares":9161100,"shares":10529300,"eps":-7.24205,"marketStatus":"Post-Mkt","change":0.01,"latestTime":"02-09 16:15:23 EST","open":1.18,"high":1.25,"low":1.1434,"amount":398091.81770400004,"amplitude":0.092696,"askPrice":1.2,"askSize":2424,"bidPrice":1.12,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-7.24205,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1770685200000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":1.15,"preHourTrading":{"tag":"盘前","latestPrice":1.1896,"preClose":1.15,"latestTime":"09:25 EST","volume":8419,"amount":10120.5691414,"timestamp":1770647159060,"change":0.0396,"changeRate":0.034435,"amplitude":0.052174},"postHourTrading":{"tag":"盘后","latestPrice":1.16,"preClose":1.16,"latestTime":"16:10 EST","volume":139,"amount":161.23999999999998,"timestamp":1770671404517,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.123716,"impliedVol":0.406,"impliedVolPercentile":0.1981},"requestUrl":"/m/hq/s/XAIR","defaultTab":"news","newsList":[{"id":"2609307978","title":"Analysts’ Top Healthcare Picks: Beyond Air (XAIR), Molina Healthcare (MOH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2609307978","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609307978?lang=en_us&edition=fundamental","pubTime":"2026-02-06 00:20","pubTimestamp":1770308414,"startTime":"0","endTime":"0","summary":"Analysts fell to the sidelines weighing in on Beyond Air (XAIR – Research Report) and Molina Healthcare (MOH – Research Report) with neutral rating...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-beyond-air-xair-molina-healthcare-moh-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-beyond-air-xair-molina-healthcare-moh-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4588","XBI","BK4532","BK4154","BK4082","XAIR","SG9999014005.SGD","MOH","BK4585","SG9999014039.USD","LABU","XLV","SG9999014021.USD","SG9999014013.SGD"],"gpt_icon":0},{"id":"2608364502","title":"Beyond Air-Tochter Beyond Cancer präsentiert Phase-1-Daten zu UNO-Therapie auf AACR 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2608364502","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608364502?lang=en_us&edition=fundamental","pubTime":"2026-02-04 21:02","pubTimestamp":1770210144,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beyond Air Inc. published the original content used to generate this news brief via GlobeNewswire  on February 04, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nNDL1qdJK4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","SG9999014039.USD","SG9999014013.SGD","LU2210149790.SGD","BK4588","BK4112","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","BK4082","BK4585","NDAQ","LU2210150020.SGD","LU2095319765.USD","SG9999014005.SGD","SG9999014021.USD","IE00B64PRP62.GBP","IE00BKPKM429.USD","XAIR"],"gpt_icon":0},{"id":"2607214540","title":"Beyond Air files to sell 7.86M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2607214540","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607214540?lang=en_us&edition=fundamental","pubTime":"2026-01-31 05:10","pubTimestamp":1769807438,"startTime":"0","endTime":"0","summary":"16:05 EST Beyond Air (XAIR) files to sell 7.86M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, m...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beyond-air-files-to-sell-7-86m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beyond-air-files-to-sell-7-86m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XAIR","BK4082"],"gpt_icon":0},{"id":"2607056081","title":"XTL Biopharmaceuticals Moves to Acquire 85% Stake in NeuroNOS Ltd","url":"https://stock-news.laohu8.com/highlight/detail?id=2607056081","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607056081?lang=en_us&edition=fundamental","pubTime":"2026-01-30 05:07","pubTimestamp":1769720865,"startTime":"0","endTime":"0","summary":"XTL Biopharmaceuticals Ltd. is working to finalize the acquisition of 85% of the shares of NeuroNOS Ltd. from Beyond Air Inc., following a binding letter of intent signed on January 13, 2026. The company has scheduled a shareholders meeting for February 17, 2026 to approve a private placement of up to US$2 million, which, along with the proposed acquisition, is expected to address a deficiency in stockholders' equity under Nasdaq listing requirements. XTL's management cautions that there is no assurance the acquisition will close or that the private placement will be approved in a timely manner, and notes ongoing efforts to regain compliance with Nasdaq rules.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. XTL Biopharmaceuticals Ltd. p","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nNDL9hDNy1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LU0314104364.USD","SG9999014005.SGD","SG9999014013.SGD","BK4112","IE00BGHQF748.EUR","SG9999014021.USD","IE00B64PRP62.GBP","XAIR","NDAQ","LU2210149790.SGD","LU2210150020.SGD","LU2095319765.USD","IE00B3QW5Z07.USD","SG9999014039.USD","BK4585","BK4588","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2606758512","title":"Beyond Air CEO to Present at Virtual Healthcare Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2606758512","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606758512?lang=en_us&edition=fundamental","pubTime":"2026-01-28 05:06","pubTimestamp":1769547965,"startTime":"0","endTime":"0","summary":"Beyond Air Inc. will participate in the Noble Capital Markets Emerging Growth Virtual Equity Conference with a corporate presentation scheduled for Thursday, February 5th at 2:00pm ET. Steve Lisi, Chairman and CEO, will also attend the 13th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference for one-on-one meetings from February 9th to 11th.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beyond Air Inc. published the original content used to generate this news brief via GlobeNewswire  on January 27, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nNDL4HJM1t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XAIR","BK4588","BK4082","LU2095319765.USD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","SG9999014021.USD","LU2210150020.SGD","SG9999014005.SGD","SG9999014013.SGD","NDAQ","IE00B64PRP62.GBP","BK4112","IE00BGHQF748.EUR","SG9999014039.USD","LU2210149790.SGD","LU0314104364.USD","BK4585"],"gpt_icon":0},{"id":"2606226364","title":"Beyond Air Inc. to Announce Third Fiscal Quarter 2026 Financial Results via Conference Call and Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2606226364","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606226364?lang=en_us&edition=fundamental","pubTime":"2026-01-27 05:05","pubTimestamp":1769461543,"startTime":"0","endTime":"0","summary":"Beyond Air Inc. will report its third fiscal quarter 2026 financial results on Friday, February 13, 2026. The company’s management team will host a conference call and webcast at 8:00 AM ET the same day. The results will be available in the Events section of the Company's website  and the webcast can be accessed directly at webcast of the live conference call. An online replay will also be available on the Company’s website an hour after the call.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beyond Air Inc. published the original content used to generate this news brief via GlobeNewswire  on January 26, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nNDLXps71:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BK4082","LU0314104364.USD","LU2210149790.SGD","IE00B64PRP62.GBP","SG9999014005.SGD","SG9999014021.USD","SG9999014013.SGD","BK4585","XAIR","SG9999014039.USD","LU2210150020.SGD","NDAQ","IE00B3QW5Z07.USD","BK4588","LU2095319765.USD","IE00BKPKM429.USD","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2605110496","title":"Beyond Air Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2605110496","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605110496?lang=en_us&edition=fundamental","pubTime":"2026-01-21 20:30","pubTimestamp":1768998600,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/XAIR/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 21, 2026 07:30 ET (12:30 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XAIR","BK4082"],"gpt_icon":0},{"id":"2604118065","title":"Beyond Air initiated with a Buy at Rodman & Renshaw","url":"https://stock-news.laohu8.com/highlight/detail?id=2604118065","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604118065?lang=en_us&edition=fundamental","pubTime":"2026-01-20 20:35","pubTimestamp":1768912520,"startTime":"0","endTime":"0","summary":"Rodman & Renshaw initiated coverage of Beyond Air (XAIR) with a Buy rating and $5 price target Published first on TheFly – the ultimate source for ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beyond-air-initiated-with-a-buy-at-rodman-renshaw-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beyond-air-initiated-with-a-buy-at-rodman-renshaw-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XAIR","BK4082"],"gpt_icon":0},{"id":"2603460152","title":"XTL Biopharmaceuticals Acquires 85% Stake in Beyond Air’s NeuroNOS Subsidiary","url":"https://stock-news.laohu8.com/highlight/detail?id=2603460152","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603460152?lang=en_us&edition=fundamental","pubTime":"2026-01-15 19:20","pubTimestamp":1768476044,"startTime":"0","endTime":"0","summary":"XTL Biopharmaceuticals has entered into a binding agreement to acquire 85% of NeuroNOS Ltd., a subsidiary of Beyond Air, Inc. NeuroNOS focuses on developing disease-modifying therapeutics for Autism Spectrum Disorder  and neuro-oncology, targeting the core biology of autism rather than just providing symptomatic relief. As part of the transaction, Beyond Air will retain a 19.99% stake in XTL’s post-transaction share capital and may receive up to $32.5 million in upfront, development, and commercial milestone payments. The deal brings together a scientific team that includes two Nobel Laureates and Professor Haitham Amal, with the aim of advancing innovative treatments for autism and related conditions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nNDLbVD2Sh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","XAIR"],"gpt_icon":0},{"id":"2603619922","title":"Beyond Air Raises $5 Million in Private Placement of Common Stock and Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2603619922","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603619922?lang=en_us&edition=fundamental","pubTime":"2026-01-14 21:31","pubTimestamp":1768397500,"startTime":"0","endTime":"0","summary":"Beyond Air Inc. has announced a $5.0 million private placement of its common stock and warrants, priced at-the-market under Nasdaq rules. The company will issue approximately 3.9 million shares of common stock  and corresponding warrants to purchase the same number of shares, at a combined price of $1.272 per share and warrant. The warrants will have an exercise price of $1.147 per share and a five-year term. This unregistered sale is being made to an institutional investor, with the company agreeing to file registration statements for the resale of the shares. Proceeds from the offering will be used for working capital and general corporate purposes. Rodman & Renshaw LLC is serving as exclusive placement agent, with Roth Capital Partners and D. Boral Capital acting as financial advisors. Closing is expected around January 16, 2026, pending customary conditions.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nNDL9HjB0t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","SG9999014005.SGD","LU0314104364.USD","NDAQ","SG9999014021.USD","IE00BGHQF748.EUR","BK4588","SG9999014013.SGD","LU2210150020.SGD","LU2210149790.SGD","IE00B64PRP62.GBP","XAIR","IE00BKPKM429.USD","BK4112","BK4585","LU2095319765.USD","SG9999014039.USD","BK4082"],"gpt_icon":0},{"id":"2603461916","title":"Press Release: Beyond Air Announces $5.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2603461916","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603461916?lang=en_us&edition=fundamental","pubTime":"2026-01-14 21:30","pubTimestamp":1768397400,"startTime":"0","endTime":"0","summary":"GARDEN CITY, N.Y., Jan. 14, 2026  -- Beyond Air, Inc.  , a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide to improve the lives of patients, today announced that it entered into a securities purchase agreement with an institutional investor to issue and sell, in a private placement priced at-the-market under Nasdaq rules, 3,930,818 shares of common stock , and warrants to purchase up to an aggregate of 3,930,818 shares of common stock, at a combined purchase price of $1.272 per share of common stock  and associated warrant, for expected gross proceeds of approximately $5.0 million, before deducting placement agent fees and other offering expenses payable by the Company. The warrants will have an exercise price of $1.147 per share of common stock and will be exercisable immediately upon issuance with a term of five years following the date of issuance.Beyond Air is a commercial-stage medical device and biopharmaceutical compa","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","XAIR","NQmain"],"gpt_icon":0},{"id":"2603631640","title":"Crude Oil Rises Sharply; US Inflation Rate Holds Steady At 2.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603631640","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603631640?lang=en_us&edition=fundamental","pubTime":"2026-01-14 01:37","pubTimestamp":1768325861,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"b7436e39b3a3cd3869dfcb808a444061","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/26/01/49884263/crude-oil-rises-sharply-us-inflation-rate-holds-steady-at-2-7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QQQE","QQQJ","NVIW.SI","AHMA","TVTX","BK4082","QQQY","QYLG","TSYW.SI","PSQ","GPIQ","QYLD","BK4139","USAW.SI","BK4608","BK4108","USJW.SI","XAIR","SQQQ","THH","QQQM","BK4023",".IXIC","MNQmain","BK4009","QLD","QID","NQmain","BK4135","SGN","TQQQ","WLTH"],"gpt_icon":1},{"id":"2603163564","title":"Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX), Travere Therapeutics (TVTX) and Beyond Air (XAIR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2603163564","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603163564?lang=en_us&edition=fundamental","pubTime":"2026-01-13 23:30","pubTimestamp":1768318236,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Argenx Se (ARGX – Research Report), Travere Therapeu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-argenx-se-argx-travere-therapeutics-tvtx-and-beyond-air-xair-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-argenx-se-argx-travere-therapeutics-tvtx-and-beyond-air-xair-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XAIR","XBI","ARGX","IE00BJJMRZ35.SGD","LU0320765992.SGD","BK4588","LU2324357040.USD","TVTX","IE00BFTCPJ56.SGD","LU1983260115.SGD","IE00BJT1NW94.SGD","IE0034235188.USD","BK4505","LU0128526141.USD","LU0109394709.USD","BK4139","BK4585","LU0029874061.USD","HCSG","IE00B4R5TH58.HKD","BK4082","LU0889565916.HKD","XLV","BK4137","IE0009355771.USD","BK4581","LABU","IE00B2B36J28.USD","IE0002141913.USD"],"gpt_icon":0},{"id":"2603968077","title":"XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership","url":"https://stock-news.laohu8.com/highlight/detail?id=2603968077","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603968077?lang=en_us&edition=fundamental","pubTime":"2026-01-13 22:28","pubTimestamp":1768314480,"startTime":"0","endTime":"0","summary":"Unmatched scientific firepower: Two Nobel Laureates join Founder Prof. Haitham Amal, leading global autism researcher Critical unmet need: 1 in 31 U.S. children now affected, zero FDA-approved disease","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/13/3217924/0/en/XTL-Biopharmaceuticals-Acquires-85-of-NeuroNOS-Entering-the-Massive-Autism-Market-with-Nobel-Prize-Winning-Scientific-Leadership.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4139","XTLB","XTL","BK4077","XAIR","SLE"],"gpt_icon":0},{"id":"2603689126","title":"XTL Biopharmaceuticals to Acquire NeuroNOS from Beyond Air","url":"https://stock-news.laohu8.com/highlight/detail?id=2603689126","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603689126?lang=en_us&edition=fundamental","pubTime":"2026-01-13 20:31","pubTimestamp":1768307505,"startTime":"0","endTime":"0","summary":"XTL Biopharmaceuticals Ltd. has entered into a binding letter of intent with Beyond Air, Inc. for the proposed acquisition of NeuroNOS Ltd., a private Israeli biopharmaceutical company focused on developing treatments for Autism Spectrum Disorder, Alzheimer’s disease, and brain cancers. Under the agreement, Beyond Air, which currently holds 85% of NeuroNOS, will receive American Depositary Shares representing 19.99% of XTL’s outstanding share capital, three-year warrants to maintain this ownership level, a $1 million cash payment within 60 days of closing, and potential milestone payments up to $5.5 million or a single lump sum of $4 million. Additional commercial milestone payments ranging from $2 million to $12.5 million are also contingent on cumulative net sales of the first NeuroNOS product. XTL intends to offer the remaining NeuroNOS shareholders the opportunity to exchange their shares for XTL ordinary shares after the transaction closes.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nNDL8nHL7Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","XAIR"],"gpt_icon":0},{"id":"2603689131","title":"X T L Biopharmaceuticals Ltd: Beyond Air to Receive up to $32.5 Mln in Upfront, Development and Commercial Milestone Payments","url":"https://stock-news.laohu8.com/highlight/detail?id=2603689131","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603689131?lang=en_us&edition=fundamental","pubTime":"2026-01-13 20:30","pubTimestamp":1768307406,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nFWN3YE0K4:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["XAIR","BK4082"],"gpt_icon":0},{"id":"2603134689","title":"X T L Biopharmaceuticals Ltd: Neuronos Will NOW Serve as Xtl's Flagship Platform for Autism and Neuro-Oncology Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2603134689","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603134689?lang=en_us&edition=fundamental","pubTime":"2026-01-13 20:30","pubTimestamp":1768307406,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nFWN3YE0K4:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["XAIR","BK4082"],"gpt_icon":0},{"id":"2601318843","title":"Beyond Air Inc. Files Initial Beneficial Ownership Statement for CFO Daniel Moorhead","url":"https://stock-news.laohu8.com/highlight/detail?id=2601318843","media":"Reuters","labels":["executive","shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601318843?lang=en_us&edition=fundamental","pubTime":"2026-01-07 05:16","pubTimestamp":1767734175,"startTime":"0","endTime":"0","summary":"Beyond Air Inc. has filed an initial statement of beneficial ownership  with the U.S. Securities and Exchange Commission. The filing lists Daniel J. Moorhead as the beneficial owner in his role as Chief Financial Officer. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beyond Air Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 06, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nNDL5FF5ry:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Beyond Air Inc. Files Initial Beneficial Ownership Statement for CFO Daniel Moorhead","news_tag":"executive,shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XAIR","BK4082"],"gpt_icon":0},{"id":"2595792302","title":"Beyond Air Names Dan Moorhead Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2595792302","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595792302?lang=en_us&edition=fundamental","pubTime":"2025-12-30 20:30","pubTimestamp":1767097830,"startTime":"0","endTime":"0","summary":"Beyond Air Inc. has appointed Dan Moorhead as Chief Financial Officer, effective January 5, 2026. Duke Dewrell, who had been serving as interim CFO, will resume his previous role as Controller. Moorhead brings over 20 years of finance leadership experience, including prior roles as CFO at Zynex, Inc. and Evolving Systems, Inc.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beyond Air Inc. published the original content used to generate this news brief via GlobeNewswire  on December 30, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nNDL17Tscf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4023","LU0314104364.USD","SG9999014013.SGD","LU2210150020.SGD","IE00B64PRP62.GBP","ZYXIQ","BK4082","SG9999014005.SGD","IE00BKPKM429.USD","SG9999014021.USD","IE00B3QW5Z07.USD","BK4112","SG9999014039.USD","LU2210149790.SGD","BK4588","NDAQ","XAIR","IE00BGHQF748.EUR","EVOL","LU2095319765.USD"],"gpt_icon":0},{"id":"2595928207","title":"Beyond Air® Appoints Dan Moorhead as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2595928207","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595928207?lang=en_us&edition=fundamental","pubTime":"2025-12-30 20:30","pubTimestamp":1767097801,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nTUA2X5YJX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["XAIR","BK4082"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.beyondair.net","stockEarnings":[{"period":"1week","weight":-0.0336},{"period":"1month","weight":0.3872},{"period":"3month","weight":-0.3466},{"period":"6month","weight":-0.6167},{"period":"1year","weight":-0.8562},{"period":"ytd","weight":0.584}],"compareEarnings":[{"period":"1week","weight":-0.002},{"period":"1month","weight":0.0015},{"period":"3month","weight":0.0293},{"period":"6month","weight":0.0839},{"period":"1year","weight":0.139},{"period":"ytd","weight":0.0128}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.079389},{"month":2,"riseRate":0.571429,"avgChangeRate":0.054406},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.049995},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.145091},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.037448},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.058187},{"month":7,"riseRate":0.5,"avgChangeRate":0.040624},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.051334},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.093473},{"month":10,"riseRate":0.428571,"avgChangeRate":0.021382},{"month":11,"riseRate":0.428571,"avgChangeRate":-0.048124},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.099782}],"exchange":"NASDAQ","name":"Beyond Air, Inc.","nameEN":"Beyond Air, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Beyond Air, Inc.(XAIR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Beyond Air, Inc.(XAIR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Beyond Air, Inc.,XAIR,Beyond Air, Inc.股票,Beyond Air, Inc.股票老虎,Beyond Air, Inc.股票老虎国际,Beyond Air, Inc.行情,Beyond Air, Inc.股票行情,Beyond Air, Inc.股价,Beyond Air, Inc.股市,Beyond Air, Inc.股票价格,Beyond Air, Inc.股票交易,Beyond Air, Inc.股票购买,Beyond Air, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Beyond Air, Inc.(XAIR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Beyond Air, Inc.(XAIR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}